Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy

PURPOSE: To describe the occurrence of corneal thinning in a patient following intrastromal injection of bevacizumab to treat lipid keratopathy. OBSERVATIONS: A 36-year-old female presented with decreased vision in her right eye with central posterior corneal haze and underwent a treatment regimen i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Kristie J., Jun, Albert S., Bohm, Kelley, Daroszewski, Daniel, Jabbour, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253579/
https://www.ncbi.nlm.nih.gov/pubmed/35800403
http://dx.doi.org/10.1016/j.ajoc.2022.101618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253579/
https://www.ncbi.nlm.nih.gov/pubmed/35800403
http://dx.doi.org/10.1016/j.ajoc.2022.101618

Ejemplares similares